UVISERT Trademark

Trademark Overview

On Friday, April 10, 2015, a trademark application was filed for UVISERT with the United States Patent and Trademark Office. The USPTO has given the UVISERT trademark a serial number of 86593739. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 10, 2018. This trademark is owned by pSivida US, Inc.. The UVISERT trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma; pharmaceutical preparations for the treatment of ocular diseases and conditions, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma

Sustained drug delivery systems for ocular drugs
uvisert

General Information

Serial Number86593739
Word MarkUVISERT
Filing DateFriday, April 10, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 10, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2015

Trademark Statements

Goods and ServicesDrug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of ocular diseases and conditions, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma; pharmaceutical preparations for the treatment of ocular diseases and conditions, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma
Goods and ServicesSustained drug delivery systems for ocular drugs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 20, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, April 20, 2015
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEYEPOINT PHARMACEUTICALS US, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressWATERTOWN, MA 02472
Party NamepSivida US, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NamepSivida US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events

Event DateEvent Description
Monday, December 10, 2018ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 10, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 30, 2018EXTENSION 5 GRANTED
Wednesday, April 25, 2018EXTENSION 5 FILED
Wednesday, April 25, 2018TEAS EXTENSION RECEIVED
Wednesday, April 18, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, December 7, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 7, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 3, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 1, 2017EXTENSION 4 GRANTED
Wednesday, November 1, 2017EXTENSION 4 FILED
Wednesday, November 1, 2017TEAS EXTENSION RECEIVED
Friday, April 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 19, 2017EXTENSION 3 GRANTED
Wednesday, April 19, 2017EXTENSION 3 FILED
Wednesday, April 19, 2017TEAS EXTENSION RECEIVED
Friday, November 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 17, 2016EXTENSION 2 GRANTED
Wednesday, November 2, 2016EXTENSION 2 FILED
Thursday, November 17, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 2, 2016TEAS EXTENSION RECEIVED
Saturday, April 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 14, 2016EXTENSION 1 GRANTED
Thursday, April 14, 2016EXTENSION 1 FILED
Thursday, April 14, 2016TEAS EXTENSION RECEIVED
Tuesday, November 3, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 8, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2015PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, August 1, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 31, 2015ASSIGNED TO LIE
Monday, July 20, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 20, 2015EXAMINER'S AMENDMENT ENTERED
Monday, July 20, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 20, 2015EXAMINERS AMENDMENT E-MAILED
Monday, July 20, 2015EXAMINERS AMENDMENT -WRITTEN
Monday, July 20, 2015ASSIGNED TO EXAMINER
Monday, July 20, 2015ASSIGNED TO EXAMINER
Monday, April 20, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 14, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

uvisert retinal disease macular delivery ocular uveitis vein occlusion edema drug